Business Wire

OR-LATTICE-SEMICONDUCTOR

8.12.2020 22:02:11 CET | Business Wire | Press release

Share
Lattice Launches 2nd Generation Security Solution with New Mach-NX FPGA for Next Generation, Cyber-Resilient Systems

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the Lattice Mach™-NX FPGA family, the second generation in its successful line of secure control FPGAs. Building on the capabilities of the Lattice MachXO3D™ family announced in 2019, Mach-NX FPGAs deliver heightened security features and the fast, power-efficient processing needed to implement a real-time Hardware Root-of-Trust (HRoT) on future server platforms, as well as computing, communications, industrial, and automotive systems. Mach-NX marks the third FPGA family developed on the Lattice Nexus™ FPGA platform in a year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201208005194/en/

“The race is on between bad actors trying to exploit firmware vulnerabilities and developers designing server platforms with the security features and performance to stop them,” said Patrick Moorhead, president and founder of Moor Insights & Strategy. “Protecting systems better requires a real-time HRoT with support for stronger cryptography algorithms like ECC 384 and new, robust data security protocols like SPDM. I believe technologies like Lattice’s Mach FPGA families can simplify and accelerate implementation of these technologies for server OEMs looking to better secure their platforms against cyberattack and IP theft.”

Esam Elashmawi, Chief Strategy and Marketing Officer at Lattice, added: “Securing systems against unauthorized firmware access goes beyond establishing a HRoT at boot. It also requires that components used to build the system are not compromised as they move through the global supply chain. When combined with the additional protection afforded by our SupplyGuard security service, Lattice Mach-NX FPGAs can protect a system throughout its entire lifecycle: beginning at the time components start moving through the supply chain, through initial product assembly, end-product shipping, integration, and throughout the product’s operational lifetime.”

Building on the system control capabilities of the Mach family, Mach-NX FPGAs combine a secure enclave (an advanced, 384-bit hardware-based crypto engine supporting reprogrammable bitstream protection) with a logic cell (LC) and I/O block. The secure enclave helps secure firmware, and the LC and I/O block enable system control functions such as power management and fan control. Mach-NX FPGAs can verify and install the over-the-air firmware updates that keep systems compliant with evolving security guidelines and protocols. The Mach-NX FPGA’s parallel processing architecture and dual-boot flash memory configuration provide the near instantaneous response times needed to detect and recover from attacks (a level of performance beyond the capabilities of other HRoT platforms like MCUs). Mach-NX FPGAs will support the Lattice Sentry™ solutions stack, a robust combination of customizable embedded software, reference designs, IP, and development tools to accelerate the implementation of secure systems compliant with NIST Platform Firmware Resiliency (PFR) Guidelines (NIST SP-800-193).

Key features of the Mach-NX family include:

  • Secure system control – Mach-NX FPGAs’ logic (up to 11K LCs) and high I/O count (up to 379) enable fast and secure system control. Lattice is a long-standing leader in programmable logic for system control. Mach FPGAs have an attach rate of over 80 percent on current shipping server platforms.
  • Robust standards and protocol compliance – the Mach-NX FPGAs’ 384-bit hardware crypto engine supports quick-and-easy implementation of leading-edge cryptography like ECC 384 and industry-standard security protocols such as NIST SP-800-193 and MCTP-SPDM . Upcoming server platforms will require support for these protocols.
  • End-to-end supply chain protection – Mach-NX FPGAs are supported by the Lattice SupplyGuard™ supply chain security subscription service. SupplyGuard gives OEMs and ODMs peace-of-mind by tracking locked Lattice FPGAs through their entire lifecycle, from the point of manufacture, through transport via the global supply chain, system integration and assembly, initial configuration, and deployment.
  • Rapidly customizable – the Lattice Propel™ design environment accelerates design of a customized, PFR-compliant HRoT solution. The tool uses a GUI-based development environment that allows developers to create PFR solutions while minimizing the need to write RTL code.

For More Information

To learn more about the Lattice technologies mentioned above, please visit:

About Lattice Semiconductor

Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.

For more information about Lattice, please visit www.latticesemi.com . You can also follow us via LinkedIn , Twitter , Facebook , YouTube , WeChat , Weibo or Youku .

Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries.

GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye